Clinical Trial Update: Alzheimer Patients and the Snoezelen Program [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the Snoezelen multisensory program for dementia, including Alzheimer's disease. The study, sponsored by Queen's Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Snippet

Sponsor: Queen's University | Conditions: Dementia | Phase 1 | Status: COMPLETED